Andras Borsi (András Borsi)

Publication Activity (10 Years)

Years Active: 2019-2021
Publications (10 Years): 6

Top Topics

Ulcerative Colitis

Patient Reported

Ejection Fraction

Decision Making

Top Venues

Scandinavian journal of gastroenterology

Current medical research and opinion

Expert opinion on biological therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Niels Qvist, Kasper Vadstrup, Sarah Alulis, Andras Borsi, Pia Munkholm, Jens Olsen
Increased use of biologics in the era of TNF-α inhibitors did not reduce surgical rate but prolonged the time from diagnosis to first time intestinal resection among patients with Crohn's disease and ulcerative colitis - a Danish register-based study from 2003-2016. Scandinavian journal of gastroenterology 56 (5) (2021)
Taina Sipponen, Clas-Göran Af Björkesten, Taru Hallinen, Tuire Ilus, Erkki Soini, Anja Eberl, Mikko Heikura, Mikko Kellokumpu, Ritva Koskela, Christian Nielsen, Heikki Nuutinen, Markku Heikkinen, Ulla-Maija Suhonen, Jyrki Tillonen, E Christina M Wennerström, Andras Borsi, Minni R Koivunen, null null
A nationwide real-world study on dynamic ustekinumab dosing and concomitant medication use among Crohn's disease patients in Finland. Scandinavian journal of gastroenterology 56 (6) (2021)
Péter Kunovszki, Kata Judit Szántó, Judit Gimesi-Országh, Péter Takács, Andras Borsi, Anita Bálint, Klaudia Farkas, Ágnes Csontos, Péter L Lakatos, Tamás Szamosi, Tamás Molnár
Epidemiological data and utilization patterns of anti-TNF alpha therapy in the Hungarian ulcerative colitis population between 2012-2016. Expert opinion on biological therapy 20 (4) (2020)
Sarah Alulis, Kasper Vadstrup, Andras Borsi, Agnete Nielsen, Tine Rikke Jørgensen, Niels Qvist, Pia Munkholm
Treatment patterns for biologics in ulcerative colitis and Crohn's disease: a Danish Nationwide Register Study from 2003 to 2015. Scandinavian journal of gastroenterology 55 (3) (2020)
Kasper Vadstrup, Sarah Alulis, Andras Borsi, Sandra Elkjaer Stallknecht, Agnete Nielsen, Tine Rikke Jørgensen, Christina Wennerström, Niels Qvist, Pia Munkholm
Societal costs attributable to Crohn's disease and ulcerative colitis within the first 5 years after diagnosis: a Danish nationwide cost-of-illness study 2002-2016. Scandinavian journal of gastroenterology 55 (1) (2020)
Nathalie C Gemayel, Eugenio Rizzello, Petar Atanasov, Daniel Wirth, Andras Borsi
Dose escalation and switching of biologics in ulcerative colitis: a systematic literature review in real-world evidence. Current medical research and opinion 35 (11) (2019)